Medical Care

Global Anti-IgG antibody Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Anti-IgG antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-IgG antibody.
The Anti-IgG antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-IgG antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-IgG antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BosterBio
Bio-Rad
ProSci
BD Biosciences
Biorbyt
R&D Systems
Bethyl Laboratories
Dianova
BioLegend
Abbexa
SouthernBiotech
Thermo Fisher Scientific
Immundiagnostik
MyBioSource
BMA Biomedicals
Novus Biologicals
Cell Sciences
Rockland Immunochemicals
QED Bioscience
Miltenyi Biotec
Jackson ImmunoResearch Laboratories
Advansta
Affinity Immuno
Antigenix America
Promega
Abeomics
Anogen
AIVD Biotech
Sino Biological
Tonbo Biosciences
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-IgG antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-IgG antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global Anti-IgG antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-IgG antibody Market Perspective (2020-2031)
2.2 Global Anti-IgG antibody Growth Trends by Region
2.2.1 Global Anti-IgG antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-IgG antibody Historic Market Size by Region (2020-2025)
2.2.3 Anti-IgG antibody Forecasted Market Size by Region (2026-2031)
2.3 Anti-IgG antibody Market Dynamics
2.3.1 Anti-IgG antibody Industry Trends
2.3.2 Anti-IgG antibody Market Drivers
2.3.3 Anti-IgG antibody Market Challenges
2.3.4 Anti-IgG antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-IgG antibody Players by Revenue
3.1.1 Global Top Anti-IgG antibody Players by Revenue (2020-2025)
3.1.2 Global Anti-IgG antibody Revenue Market Share by Players (2020-2025)
3.2 Global Anti-IgG antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-IgG antibody Revenue
3.4 Global Anti-IgG antibody Market Concentration Ratio
3.4.1 Global Anti-IgG antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-IgG antibody Revenue in 2024
3.5 Global Key Players of Anti-IgG antibody Head office and Area Served
3.6 Global Key Players of Anti-IgG antibody, Product and Application
3.7 Global Key Players of Anti-IgG antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-IgG antibody Breakdown Data by Type
4.1 Global Anti-IgG antibody Historic Market Size by Type (2020-2025)
4.2 Global Anti-IgG antibody Forecasted Market Size by Type (2026-2031)
5 Anti-IgG antibody Breakdown Data by Application
5.1 Global Anti-IgG antibody Historic Market Size by Application (2020-2025)
5.2 Global Anti-IgG antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-IgG antibody Market Size (2020-2031)
6.2 North America Anti-IgG antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-IgG antibody Market Size by Country (2020-2025)
6.4 North America Anti-IgG antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-IgG antibody Market Size (2020-2031)
7.2 Europe Anti-IgG antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-IgG antibody Market Size by Country (2020-2025)
7.4 Europe Anti-IgG antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-IgG antibody Market Size (2020-2031)
8.2 Asia-Pacific Anti-IgG antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-IgG antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-IgG antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-IgG antibody Market Size (2020-2031)
9.2 Latin America Anti-IgG antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-IgG antibody Market Size by Country (2020-2025)
9.4 Latin America Anti-IgG antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-IgG antibody Market Size (2020-2031)
10.2 Middle East & Africa Anti-IgG antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-IgG antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-IgG antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BosterBio
11.1.1 BosterBio Company Details
11.1.2 BosterBio Business Overview
11.1.3 BosterBio Anti-IgG antibody Introduction
11.1.4 BosterBio Revenue in Anti-IgG antibody Business (2020-2025)
11.1.5 BosterBio Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Details
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad Anti-IgG antibody Introduction
11.2.4 Bio-Rad Revenue in Anti-IgG antibody Business (2020-2025)
11.2.5 Bio-Rad Recent Development
11.3 ProSci
11.3.1 ProSci Company Details
11.3.2 ProSci Business Overview
11.3.3 ProSci Anti-IgG antibody Introduction
11.3.4 ProSci Revenue in Anti-IgG antibody Business (2020-2025)
11.3.5 ProSci Recent Development
11.4 BD Biosciences
11.4.1 BD Biosciences Company Details
11.4.2 BD Biosciences Business Overview
11.4.3 BD Biosciences Anti-IgG antibody Introduction
11.4.4 BD Biosciences Revenue in Anti-IgG antibody Business (2020-2025)
11.4.5 BD Biosciences Recent Development
11.5 Biorbyt
11.5.1 Biorbyt Company Details
11.5.2 Biorbyt Business Overview
11.5.3 Biorbyt Anti-IgG antibody Introduction
11.5.4 Biorbyt Revenue in Anti-IgG antibody Business (2020-2025)
11.5.5 Biorbyt Recent Development
11.6 R&D Systems
11.6.1 R&D Systems Company Details
11.6.2 R&D Systems Business Overview
11.6.3 R&D Systems Anti-IgG antibody Introduction
11.6.4 R&D Systems Revenue in Anti-IgG antibody Business (2020-2025)
11.6.5 R&D Systems Recent Development
11.7 Bethyl Laboratories
11.7.1 Bethyl Laboratories Company Details
11.7.2 Bethyl Laboratories Business Overview
11.7.3 Bethyl Laboratories Anti-IgG antibody Introduction
11.7.4 Bethyl Laboratories Revenue in Anti-IgG antibody Business (2020-2025)
11.7.5 Bethyl Laboratories Recent Development
11.8 Dianova
11.8.1 Dianova Company Details
11.8.2 Dianova Business Overview
11.8.3 Dianova Anti-IgG antibody Introduction
11.8.4 Dianova Revenue in Anti-IgG antibody Business (2020-2025)
11.8.5 Dianova Recent Development
11.9 BioLegend
11.9.1 BioLegend Company Details
11.9.2 BioLegend Business Overview
11.9.3 BioLegend Anti-IgG antibody Introduction
11.9.4 BioLegend Revenue in Anti-IgG antibody Business (2020-2025)
11.9.5 BioLegend Recent Development
11.10 Abbexa
11.10.1 Abbexa Company Details
11.10.2 Abbexa Business Overview
11.10.3 Abbexa Anti-IgG antibody Introduction
11.10.4 Abbexa Revenue in Anti-IgG antibody Business (2020-2025)
11.10.5 Abbexa Recent Development
11.11 SouthernBiotech
11.11.1 SouthernBiotech Company Details
11.11.2 SouthernBiotech Business Overview
11.11.3 SouthernBiotech Anti-IgG antibody Introduction
11.11.4 SouthernBiotech Revenue in Anti-IgG antibody Business (2020-2025)
11.11.5 SouthernBiotech Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Details
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Anti-IgG antibody Introduction
11.12.4 Thermo Fisher Scientific Revenue in Anti-IgG antibody Business (2020-2025)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 Immundiagnostik
11.13.1 Immundiagnostik Company Details
11.13.2 Immundiagnostik Business Overview
11.13.3 Immundiagnostik Anti-IgG antibody Introduction
11.13.4 Immundiagnostik Revenue in Anti-IgG antibody Business (2020-2025)
11.13.5 Immundiagnostik Recent Development
11.14 MyBioSource
11.14.1 MyBioSource Company Details
11.14.2 MyBioSource Business Overview
11.14.3 MyBioSource Anti-IgG antibody Introduction
11.14.4 MyBioSource Revenue in Anti-IgG antibody Business (2020-2025)
11.14.5 MyBioSource Recent Development
11.15 BMA Biomedicals
11.15.1 BMA Biomedicals Company Details
11.15.2 BMA Biomedicals Business Overview
11.15.3 BMA Biomedicals Anti-IgG antibody Introduction
11.15.4 BMA Biomedicals Revenue in Anti-IgG antibody Business (2020-2025)
11.15.5 BMA Biomedicals Recent Development
11.16 Novus Biologicals
11.16.1 Novus Biologicals Company Details
11.16.2 Novus Biologicals Business Overview
11.16.3 Novus Biologicals Anti-IgG antibody Introduction
11.16.4 Novus Biologicals Revenue in Anti-IgG antibody Business (2020-2025)
11.16.5 Novus Biologicals Recent Development
11.17 Cell Sciences
11.17.1 Cell Sciences Company Details
11.17.2 Cell Sciences Business Overview
11.17.3 Cell Sciences Anti-IgG antibody Introduction
11.17.4 Cell Sciences Revenue in Anti-IgG antibody Business (2020-2025)
11.17.5 Cell Sciences Recent Development
11.18 Rockland Immunochemicals
11.18.1 Rockland Immunochemicals Company Details
11.18.2 Rockland Immunochemicals Business Overview
11.18.3 Rockland Immunochemicals Anti-IgG antibody Introduction
11.18.4 Rockland Immunochemicals Revenue in Anti-IgG antibody Business (2020-2025)
11.18.5 Rockland Immunochemicals Recent Development
11.19 QED Bioscience
11.19.1 QED Bioscience Company Details
11.19.2 QED Bioscience Business Overview
11.19.3 QED Bioscience Anti-IgG antibody Introduction
11.19.4 QED Bioscience Revenue in Anti-IgG antibody Business (2020-2025)
11.19.5 QED Bioscience Recent Development
11.20 Miltenyi Biotec
11.20.1 Miltenyi Biotec Company Details
11.20.2 Miltenyi Biotec Business Overview
11.20.3 Miltenyi Biotec Anti-IgG antibody Introduction
11.20.4 Miltenyi Biotec Revenue in Anti-IgG antibody Business (2020-2025)
11.20.5 Miltenyi Biotec Recent Development
11.21 Jackson ImmunoResearch Laboratories
11.21.1 Jackson ImmunoResearch Laboratories Company Details
11.21.2 Jackson ImmunoResearch Laboratories Business Overview
11.21.3 Jackson ImmunoResearch Laboratories Anti-IgG antibody Introduction
11.21.4 Jackson ImmunoResearch Laboratories Revenue in Anti-IgG antibody Business (2020-2025)
11.21.5 Jackson ImmunoResearch Laboratories Recent Development
11.22 Advansta
11.22.1 Advansta Company Details
11.22.2 Advansta Business Overview
11.22.3 Advansta Anti-IgG antibody Introduction
11.22.4 Advansta Revenue in Anti-IgG antibody Business (2020-2025)
11.22.5 Advansta Recent Development
11.23 Affinity Immuno
11.23.1 Affinity Immuno Company Details
11.23.2 Affinity Immuno Business Overview
11.23.3 Affinity Immuno Anti-IgG antibody Introduction
11.23.4 Affinity Immuno Revenue in Anti-IgG antibody Business (2020-2025)
11.23.5 Affinity Immuno Recent Development
11.24 Antigenix America
11.24.1 Antigenix America Company Details
11.24.2 Antigenix America Business Overview
11.24.3 Antigenix America Anti-IgG antibody Introduction
11.24.4 Antigenix America Revenue in Anti-IgG antibody Business (2020-2025)
11.24.5 Antigenix America Recent Development
11.25 Promega
11.25.1 Promega Company Details
11.25.2 Promega Business Overview
11.25.3 Promega Anti-IgG antibody Introduction
11.25.4 Promega Revenue in Anti-IgG antibody Business (2020-2025)
11.25.5 Promega Recent Development
11.26 Abeomics
11.26.1 Abeomics Company Details
11.26.2 Abeomics Business Overview
11.26.3 Abeomics Anti-IgG antibody Introduction
11.26.4 Abeomics Revenue in Anti-IgG antibody Business (2020-2025)
11.26.5 Abeomics Recent Development
11.27 Anogen
11.27.1 Anogen Company Details
11.27.2 Anogen Business Overview
11.27.3 Anogen Anti-IgG antibody Introduction
11.27.4 Anogen Revenue in Anti-IgG antibody Business (2020-2025)
11.27.5 Anogen Recent Development
11.28 AIVD Biotech
11.28.1 AIVD Biotech Company Details
11.28.2 AIVD Biotech Business Overview
11.28.3 AIVD Biotech Anti-IgG antibody Introduction
11.28.4 AIVD Biotech Revenue in Anti-IgG antibody Business (2020-2025)
11.28.5 AIVD Biotech Recent Development
11.29 Sino Biological
11.29.1 Sino Biological Company Details
11.29.2 Sino Biological Business Overview
11.29.3 Sino Biological Anti-IgG antibody Introduction
11.29.4 Sino Biological Revenue in Anti-IgG antibody Business (2020-2025)
11.29.5 Sino Biological Recent Development
11.30 Tonbo Biosciences
11.30.1 Tonbo Biosciences Company Details
11.30.2 Tonbo Biosciences Business Overview
11.30.3 Tonbo Biosciences Anti-IgG antibody Introduction
11.30.4 Tonbo Biosciences Revenue in Anti-IgG antibody Business (2020-2025)
11.30.5 Tonbo Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Anti-IgG antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibody
Table 3. Key Players of Polyclonal Antibody
Table 4. Global Anti-IgG antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Anti-IgG antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Anti-IgG antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Anti-IgG antibody Market Share by Region (2020-2025)
Table 8. Global Anti-IgG antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Anti-IgG antibody Market Share by Region (2026-2031)
Table 10. Anti-IgG antibody Market Trends
Table 11. Anti-IgG antibody Market Drivers
Table 12. Anti-IgG antibody Market Challenges
Table 13. Anti-IgG antibody Market Restraints
Table 14. Global Anti-IgG antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Anti-IgG antibody Market Share by Players (2020-2025)
Table 16. Global Top Anti-IgG antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-IgG antibody as of 2024)
Table 17. Ranking of Global Top Anti-IgG antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Anti-IgG antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Anti-IgG antibody, Headquarters and Area Served
Table 20. Global Key Players of Anti-IgG antibody, Product and Application
Table 21. Global Key Players of Anti-IgG antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-IgG antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Anti-IgG antibody Revenue Market Share by Type (2020-2025)
Table 25. Global Anti-IgG antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Anti-IgG antibody Revenue Market Share by Type (2026-2031)
Table 27. Global Anti-IgG antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Anti-IgG antibody Revenue Market Share by Application (2020-2025)
Table 29. Global Anti-IgG antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Anti-IgG antibody Revenue Market Share by Application (2026-2031)
Table 31. North America Anti-IgG antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Anti-IgG antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Anti-IgG antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Anti-IgG antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Anti-IgG antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Anti-IgG antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Anti-IgG antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Anti-IgG antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Anti-IgG antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-IgG antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Anti-IgG antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Anti-IgG antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Anti-IgG antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Anti-IgG antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Anti-IgG antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. BosterBio Company Details
Table 47. BosterBio Business Overview
Table 48. BosterBio Anti-IgG antibody Product
Table 49. BosterBio Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 50. BosterBio Recent Development
Table 51. Bio-Rad Company Details
Table 52. Bio-Rad Business Overview
Table 53. Bio-Rad Anti-IgG antibody Product
Table 54. Bio-Rad Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 55. Bio-Rad Recent Development
Table 56. ProSci Company Details
Table 57. ProSci Business Overview
Table 58. ProSci Anti-IgG antibody Product
Table 59. ProSci Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 60. ProSci Recent Development
Table 61. BD Biosciences Company Details
Table 62. BD Biosciences Business Overview
Table 63. BD Biosciences Anti-IgG antibody Product
Table 64. BD Biosciences Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 65. BD Biosciences Recent Development
Table 66. Biorbyt Company Details
Table 67. Biorbyt Business Overview
Table 68. Biorbyt Anti-IgG antibody Product
Table 69. Biorbyt Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 70. Biorbyt Recent Development
Table 71. R&D Systems Company Details
Table 72. R&D Systems Business Overview
Table 73. R&D Systems Anti-IgG antibody Product
Table 74. R&D Systems Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 75. R&D Systems Recent Development
Table 76. Bethyl Laboratories Company Details
Table 77. Bethyl Laboratories Business Overview
Table 78. Bethyl Laboratories Anti-IgG antibody Product
Table 79. Bethyl Laboratories Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 80. Bethyl Laboratories Recent Development
Table 81. Dianova Company Details
Table 82. Dianova Business Overview
Table 83. Dianova Anti-IgG antibody Product
Table 84. Dianova Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 85. Dianova Recent Development
Table 86. BioLegend Company Details
Table 87. BioLegend Business Overview
Table 88. BioLegend Anti-IgG antibody Product
Table 89. BioLegend Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 90. BioLegend Recent Development
Table 91. Abbexa Company Details
Table 92. Abbexa Business Overview
Table 93. Abbexa Anti-IgG antibody Product
Table 94. Abbexa Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 95. Abbexa Recent Development
Table 96. SouthernBiotech Company Details
Table 97. SouthernBiotech Business Overview
Table 98. SouthernBiotech Anti-IgG antibody Product
Table 99. SouthernBiotech Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 100. SouthernBiotech Recent Development
Table 101. Thermo Fisher Scientific Company Details
Table 102. Thermo Fisher Scientific Business Overview
Table 103. Thermo Fisher Scientific Anti-IgG antibody Product
Table 104. Thermo Fisher Scientific Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 105. Thermo Fisher Scientific Recent Development
Table 106. Immundiagnostik Company Details
Table 107. Immundiagnostik Business Overview
Table 108. Immundiagnostik Anti-IgG antibody Product
Table 109. Immundiagnostik Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 110. Immundiagnostik Recent Development
Table 111. MyBioSource Company Details
Table 112. MyBioSource Business Overview
Table 113. MyBioSource Anti-IgG antibody Product
Table 114. MyBioSource Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 115. MyBioSource Recent Development
Table 116. BMA Biomedicals Company Details
Table 117. BMA Biomedicals Business Overview
Table 118. BMA Biomedicals Anti-IgG antibody Product
Table 119. BMA Biomedicals Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 120. BMA Biomedicals Recent Development
Table 121. Novus Biologicals Company Details
Table 122. Novus Biologicals Business Overview
Table 123. Novus Biologicals Anti-IgG antibody Product
Table 124. Novus Biologicals Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 125. Novus Biologicals Recent Development
Table 126. Cell Sciences Company Details
Table 127. Cell Sciences Business Overview
Table 128. Cell Sciences Anti-IgG antibody Product
Table 129. Cell Sciences Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 130. Cell Sciences Recent Development
Table 131. Rockland Immunochemicals Company Details
Table 132. Rockland Immunochemicals Business Overview
Table 133. Rockland Immunochemicals Anti-IgG antibody Product
Table 134. Rockland Immunochemicals Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 135. Rockland Immunochemicals Recent Development
Table 136. QED Bioscience Company Details
Table 137. QED Bioscience Business Overview
Table 138. QED Bioscience Anti-IgG antibody Product
Table 139. QED Bioscience Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 140. QED Bioscience Recent Development
Table 141. Miltenyi Biotec Company Details
Table 142. Miltenyi Biotec Business Overview
Table 143. Miltenyi Biotec Anti-IgG antibody Product
Table 144. Miltenyi Biotec Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 145. Miltenyi Biotec Recent Development
Table 146. Jackson ImmunoResearch Laboratories Company Details
Table 147. Jackson ImmunoResearch Laboratories Business Overview
Table 148. Jackson ImmunoResearch Laboratories Anti-IgG antibody Product
Table 149. Jackson ImmunoResearch Laboratories Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 150. Jackson ImmunoResearch Laboratories Recent Development
Table 151. Advansta Company Details
Table 152. Advansta Business Overview
Table 153. Advansta Anti-IgG antibody Product
Table 154. Advansta Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 155. Advansta Recent Development
Table 156. Affinity Immuno Company Details
Table 157. Affinity Immuno Business Overview
Table 158. Affinity Immuno Anti-IgG antibody Product
Table 159. Affinity Immuno Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 160. Affinity Immuno Recent Development
Table 161. Antigenix America Company Details
Table 162. Antigenix America Business Overview
Table 163. Antigenix America Anti-IgG antibody Product
Table 164. Antigenix America Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 165. Antigenix America Recent Development
Table 166. Promega Company Details
Table 167. Promega Business Overview
Table 168. Promega Anti-IgG antibody Product
Table 169. Promega Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 170. Promega Recent Development
Table 171. Abeomics Company Details
Table 172. Abeomics Business Overview
Table 173. Abeomics Anti-IgG antibody Product
Table 174. Abeomics Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 175. Abeomics Recent Development
Table 176. Anogen Company Details
Table 177. Anogen Business Overview
Table 178. Anogen Anti-IgG antibody Product
Table 179. Anogen Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 180. Anogen Recent Development
Table 181. AIVD Biotech Company Details
Table 182. AIVD Biotech Business Overview
Table 183. AIVD Biotech Anti-IgG antibody Product
Table 184. AIVD Biotech Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 185. AIVD Biotech Recent Development
Table 186. Sino Biological Company Details
Table 187. Sino Biological Business Overview
Table 188. Sino Biological Anti-IgG antibody Product
Table 189. Sino Biological Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 190. Sino Biological Recent Development
Table 191. Tonbo Biosciences Company Details
Table 192. Tonbo Biosciences Business Overview
Table 193. Tonbo Biosciences Anti-IgG antibody Product
Table 194. Tonbo Biosciences Revenue in Anti-IgG antibody Business (2020-2025) & (US$ Million)
Table 195. Tonbo Biosciences Recent Development
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
Table 199. Authors List of This Report


List of Figures
Figure 1. Anti-IgG antibody Picture
Figure 2. Global Anti-IgG antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-IgG antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibody Features
Figure 5. Polyclonal Antibody Features
Figure 6. Global Anti-IgG antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Anti-IgG antibody Market Share by Application: 2024 VS 2031
Figure 8. Biotechnology Case Studies
Figure 9. Medical Case Studies
Figure 10. University Case Studies
Figure 11. Others Case Studies
Figure 12. Anti-IgG antibody Report Years Considered
Figure 13. Global Anti-IgG antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Anti-IgG antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Anti-IgG antibody Market Share by Region: 2024 VS 2031
Figure 16. Global Anti-IgG antibody Market Share by Players in 2024
Figure 17. Global Top Anti-IgG antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-IgG antibody as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Anti-IgG antibody Revenue in 2024
Figure 19. North America Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Anti-IgG antibody Market Share by Country (2020-2031)
Figure 21. United States Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Anti-IgG antibody Market Share by Country (2020-2031)
Figure 25. Germany Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Anti-IgG antibody Market Share by Region (2020-2031)
Figure 33. China Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Anti-IgG antibody Market Share by Country (2020-2031)
Figure 41. Mexico Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Anti-IgG antibody Market Share by Country (2020-2031)
Figure 45. Turkey Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Anti-IgG antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. BosterBio Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 49. Bio-Rad Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 50. ProSci Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 51. BD Biosciences Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 52. Biorbyt Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 53. R&D Systems Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 54. Bethyl Laboratories Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 55. Dianova Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 56. BioLegend Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 57. Abbexa Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 58. SouthernBiotech Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 60. Immundiagnostik Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 61. MyBioSource Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 62. BMA Biomedicals Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 63. Novus Biologicals Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 64. Cell Sciences Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 65. Rockland Immunochemicals Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 66. QED Bioscience Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 67. Miltenyi Biotec Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 68. Jackson ImmunoResearch Laboratories Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 69. Advansta Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 70. Affinity Immuno Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 71. Antigenix America Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 72. Promega Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 73. Abeomics Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 74. Anogen Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 75. AIVD Biotech Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 76. Sino Biological Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 77. Tonbo Biosciences Revenue Growth Rate in Anti-IgG antibody Business (2020-2025)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies